A project from the American Society of Retina SpecialistsSign in to view content
Phase 3 Randomized Studies of Efficacy and Safety of Revakinagene Taroretcel Producing Ciliary Neurotrophic Factor (CNTF) in Macular Telangiectasia Type 2
- Video
- Published 2023
Related
Category: Retinal Vascular Disease